Spots Global Cancer Trial Database for vinblastine sulfate
Every month we try and update this database with for vinblastine sulfate cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease | NCT00000626 | HIV Infections Hodgkin's Disea... | Vinblastine sul... Dacarbazine Filgrastim Bleomycin sulfa... Doxorubicin hyd... | 12 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease | NCT00004010 | Lymphoma | bleomycin sulfa... filgrastim ABVD regimen cyclophosphamid... dacarbazine doxorubicin hyd... etoposide prednisone procarbazine hy... vinblastine sul... vincristine sul... radiation thera... | - 21 Years | Children's Oncology Group | |
| Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors | NCT00274950 | Childhood Germ ... Extragonadal Ge... Ovarian Cancer | bleomycin sulfa... carboplatin cisplatin etoposide ifosfamide vinblastine sul... adjuvant therap... conventional su... | - 17 Years | National Cancer Institute (NCI) | |
| Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer | NCT04628767 | Renal Pelvis an... | Biopsy Biospecimen Col... Cisplatin Computed Tomogr... Doxorubicin Hyd... Durvalumab Gemcitabine Hyd... Magnetic Resona... Methotrexate Pegfilgrastim Therapeutic Con... Vinblastine Sul... | 18 Years - | National Cancer Institute (NCI) | |
| Vinblastine and Methotrexate in Treating Children With Desmoid Tumors | NCT00003019 | Desmoid Tumor | methotrexate vinblastine sul... | - 21 Years | Children's Oncology Group | |
| Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer | NCT00003240 | Lung Cancer | cisplatin ifosfamide mitomycin C vinblastine sul... vindesine vinorelbine tar... conventional su... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Bladder Cancer | NCT00003701 | Bladder Cancer Urethral Cancer | carboplatin cisplatin doxorubicin hyd... methotrexate paclitaxel vinblastine sul... | 0 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease | NCT00002714 | Lymphoma | bleomycin sulfa... Stanford V regi... doxorubicin hyd... etoposide mechlorethamine... prednisone vinblastine sul... vincristine sul... radiation thera... | 16 Years - 60 Years | National Cancer Institute (NCI) | |
| Rituximab and ABVD for Hodgkin's Patients | NCT00504504 | Lymphoma | Rituximab Adriamycin Bleomycin Vinblastine Dacarbazine (DT... | 16 Years - | M.D. Anderson Cancer Center | |
| Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | NCT00004209 | Lung Cancer | cisplatin mitomycin C vinblastine sul... | 18 Years - | National Cancer Institute (NCI) | |
| Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer | NCT00003181 | Kidney Cancer | aldesleukin sargramostim vinblastine sul... | 18 Years - | National Cancer Institute (NCI) | |
| Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer | NCT00003640 | Bladder Cancer | filgrastim cisplatin doxorubicin hyd... methotrexate vinblastine sul... surgical proced... radiation thera... | - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer | NCT00083083 | Lung Cancer | carboplatin cisplatin docetaxel etoposide paclitaxel vinblastine sul... vinorelbine tar... gene expression... positron emissi... fludeoxyglucose... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium | NCT00028756 | Stage III Bladd... Stage IV Bladde... Transitional Ce... | doxorubicin hyd... gemcitabine hyd... vinblastine sul... methotrexate cisplatin filgrastim | - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Rituximab and ABVD for Hodgkin's Patients | NCT00504504 | Lymphoma | Rituximab Adriamycin Bleomycin Vinblastine Dacarbazine (DT... | 16 Years - | M.D. Anderson Cancer Center | |
| Combination Chemotherapy in Treating Patients With Bladder Cancer | NCT00003701 | Bladder Cancer Urethral Cancer | carboplatin cisplatin doxorubicin hyd... methotrexate paclitaxel vinblastine sul... | 0 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma | NCT00213278 | Glioma | vinblastine sul... | 1 Day - 21 Years | The Hospital for Sick Children | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease | NCT00002714 | Lymphoma | bleomycin sulfa... Stanford V regi... doxorubicin hyd... etoposide mechlorethamine... prednisone vinblastine sul... vincristine sul... radiation thera... | 16 Years - 60 Years | National Cancer Institute (NCI) | |
| PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma | NCT03226249 | Classical Hodgk... Lymphocyte-Depl... Lymphocyte-Rich... Mixed Cellulari... Nodular Scleros... | Computed Tomogr... Dacarbazine Doxorubicin Hyd... Fludeoxyglucose... Laboratory Biom... Pembrolizumab Positron Emissi... Vinblastine Sul... | 18 Years - | Northwestern University | |
| A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab | NCT05675410 | Lugano Classifi... | Biospecimen Col... Bleomycin Sulfa... Brentuximab Ved... Computed Tomogr... Cyclophosphamid... Dacarbazine Doxorubicin Hyd... Etoposide Etoposide Phosp... Fludeoxyglucose... Involved-site R... Magnetic Resona... Nivolumab Positron Emissi... Prednisolone Prednisone Procarbazine Hy... Questionnaire A... Vinblastine Sul... Vincristine Sul... | 5 Years - 60 Years | National Cancer Institute (NCI) | |
| A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years | NCT00079105 | Lymphoma | bleomycin sulfa... cyclophosphamid... etoposide mitoxantrone hy... prednisolone procarbazine hy... vinblastine sul... | 60 Years - 120 Years | Newcastle-upon-Tyne Hospitals NHS Trust | |
| Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors | NCT00002566 | Extragonadal Ge... Testicular Germ... | carboplatin cisplatin cyclophosphamid... etoposide ifosfamide vinblastine sul... autologous bone... conventional su... peripheral bloo... | 16 Years - 120 Years | UNICANCER | |
| Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer | NCT00003181 | Kidney Cancer | aldesleukin sargramostim vinblastine sul... | 18 Years - | National Cancer Institute (NCI) | |
| S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma | NCT00822120 | Lymphoma Nonneoplastic C... | bleomycin sulfa... filgrastim ABVD regimen BEACOPP regimen cyclophosphamid... dacarbazine doxorubicin hyd... etoposide prednisone procarbazine hy... vinblastine sul... vincristine sul... | 18 Years - 60 Years | SWOG Cancer Research Network | |
| Surgery Alone or With CYC VBL and PRED or CVP Alone in Stage IA or IIA Nodular Lymphocyte-Predominant Hodgkin Lymphoma | NCT01088750 | Lymphoma | cyclophosphamid... prednisolone vinblastine sul... watchful waitin... therapeutic con... | - 17 Years | Martin-Luther-Universität Halle-Wittenberg | |
| Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma | NCT00317408 | Lymphoma | anti-thymocyte ... busulfan carboplatin carmustine cyclosporine cytarabine dexamethasone etoposide phosp... idarubicin ifosfamide leucovorin calc... lomustine melphalan methotrexate mitoxantrone hy... prednisolone thiotepa vinblastine sul... vindesine allogeneic hema... autologous hema... peripheral bloo... total-body irra... | - 21 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma | NCT00317408 | Lymphoma | anti-thymocyte ... busulfan carboplatin carmustine cyclosporine cytarabine dexamethasone etoposide phosp... idarubicin ifosfamide leucovorin calc... lomustine melphalan methotrexate mitoxantrone hy... prednisolone thiotepa vinblastine sul... vindesine allogeneic hema... autologous hema... peripheral bloo... total-body irra... | - 21 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer | NCT00002823 | Lung Cancer | cisplatin etoposide vinblastine sul... vindesine vinorelbine tar... radiation thera... | 18 Years - 75 Years | Gustave Roussy, Cancer Campus, Grand Paris | |
| Rituximab and ABVD for Hodgkin's Patients | NCT00504504 | Lymphoma | Rituximab Adriamycin Bleomycin Vinblastine Dacarbazine (DT... | 16 Years - | M.D. Anderson Cancer Center | |
| RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease | NCT00002462 | Lymphoma | bleomycin sulfa... doxorubicin hyd... mechlorethamine... prednisone procarbazine hy... vinblastine sul... vincristine sul... low-LET cobalt-... low-LET photon ... radiation thera... | 15 Years - 70 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer | NCT04383743 | Stage II Bladde... Stage IIIA Blad... Muscle Invasive... | Cisplatin Doxorubicin Methotrexate Pegfilgrastim Pembrolizumab Radical Cystect... Vinblastine Sul... | 18 Years - | University of Washington | |
| Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma | NCT00041210 | Lymphoma | bleomycin sulfa... ABVD regimen Stanford V regi... dacarbazine doxorubicin hyd... etoposide mechlorethamine... prednisone vinblastine sul... vincristine sul... radiation thera... | 18 Years - 60 Years | National Cancer Institute (NCI) | |
| Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma | NCT00379041 | Lymphoma | bleomycin sulfa... doxorubicin hyd... mechlorethamine... prednisone procarbazine hy... vinblastine sul... vincristine sul... radiation thera... | 15 Years - 70 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer | NCT00003159 | Lung Cancer | carboplatin cisplatin docetaxel gemcitabine hyd... ifosfamide mitomycin C paclitaxel vinblastine sul... vinorelbine tar... conventional su... neoadjuvant the... | - | National Cancer Institute (NCI) | |
| RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease | NCT00002462 | Lymphoma | bleomycin sulfa... doxorubicin hyd... mechlorethamine... prednisone procarbazine hy... vinblastine sul... vincristine sul... low-LET cobalt-... low-LET photon ... radiation thera... | 15 Years - 70 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Phosphorus-32 Plus Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer | NCT00006212 | Lung Cancer | cisplatin vinblastine sul... phosphorus P32 radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma | NCT00678327 | Lymphoma | bleomycin sulfa... filgrastim pegfilgrastim cyclophosphamid... dacarbazine doxorubicin hyd... etoposide prednisolone procarbazine hy... vinblastine sul... vincristine sul... | 18 Years - 100 Years | University College, London | |
| Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma | NCT01132807 | Lymphoma | Bleomycin Sulfa... Doxorubicin Hyd... Procarbazine Hy... Vinblastine Sul... Dacarbazine Cyclophosphamid... Etoposide phosp... prednisone Radiation Thera... Fludeoxyglucose... computed tomogr... Positron Emissi... | 18 Years - 60 Years | Alliance for Clinical Trials in Oncology | |
| Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma | NCT00059839 | Lymphoma | doxorubicin hyd... mercaptopurine methotrexate prednisone vinblastine sul... vincristine sul... | - 20 Years | Children's Oncology Group | |
| Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma | NCT03907488 | Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Classic Hodgkin... Lymphocyte-Rich... | Biospecimen Col... Brentuximab Ved... Computed Tomogr... Dacarbazine Doxorubicin Hyd... Filgrastim Magnetic Resona... Nivolumab Pegfilgrastim Positron Emissi... Quality-of-Life... Questionnaire A... Radiation Thera... Vinblastine Sul... | 12 Years - | National Cancer Institute (NCI) | |
| Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer | NCT04628767 | Renal Pelvis an... | Biopsy Biospecimen Col... Cisplatin Computed Tomogr... Doxorubicin Hyd... Durvalumab Gemcitabine Hyd... Magnetic Resona... Methotrexate Pegfilgrastim Therapeutic Con... Vinblastine Sul... | 18 Years - | National Cancer Institute (NCI) | |
| Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer | NCT04383743 | Stage II Bladde... Stage IIIA Blad... Muscle Invasive... | Cisplatin Doxorubicin Methotrexate Pegfilgrastim Pembrolizumab Radical Cystect... Vinblastine Sul... | 18 Years - | University of Washington | |
| Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma | NCT00041210 | Lymphoma | bleomycin sulfa... ABVD regimen Stanford V regi... dacarbazine doxorubicin hyd... etoposide mechlorethamine... prednisone vinblastine sul... vincristine sul... radiation thera... | 18 Years - 60 Years | National Cancer Institute (NCI) | |
| Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer | NCT00003640 | Bladder Cancer | filgrastim cisplatin doxorubicin hyd... methotrexate vinblastine sul... surgical proced... radiation thera... | - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Rituximab and ABVD for Hodgkin's Patients | NCT00504504 | Lymphoma | Rituximab Adriamycin Bleomycin Vinblastine Dacarbazine (DT... | 16 Years - | M.D. Anderson Cancer Center | |
| Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer | NCT00003240 | Lung Cancer | cisplatin ifosfamide mitomycin C vinblastine sul... vindesine vinorelbine tar... conventional su... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical Cancer | NCT00003209 | Cervical Cancer | bleomycin sulfa... cisplatin fluorouracil ifosfamide methotrexate mitomycin C vinblastine sul... vindesine radiation thera... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma | NCT00059839 | Lymphoma | doxorubicin hyd... mercaptopurine methotrexate prednisone vinblastine sul... vincristine sul... | - 20 Years | Children's Oncology Group | |
| Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma | NCT00059839 | Lymphoma | doxorubicin hyd... mercaptopurine methotrexate prednisone vinblastine sul... vincristine sul... | - 20 Years | Children's Oncology Group | |
| Combination Chemotherapy in Treating Patients With Bladder Cancer | NCT00003701 | Bladder Cancer Urethral Cancer | carboplatin cisplatin doxorubicin hyd... methotrexate paclitaxel vinblastine sul... | 0 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer | NCT00030654 | Prostate Cancer | bicalutamide docetaxel doxorubicin hyd... estramustine ph... flutamide ketoconazole paclitaxel releasing hormo... vinblastine sul... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors | NCT00274950 | Childhood Germ ... Extragonadal Ge... Ovarian Cancer | bleomycin sulfa... carboplatin cisplatin etoposide ifosfamide vinblastine sul... adjuvant therap... conventional su... | - 17 Years | National Cancer Institute (NCI) | |
| Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer | NCT04628767 | Renal Pelvis an... | Biopsy Biospecimen Col... Cisplatin Computed Tomogr... Doxorubicin Hyd... Durvalumab Gemcitabine Hyd... Magnetic Resona... Methotrexate Pegfilgrastim Therapeutic Con... Vinblastine Sul... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma | NCT00005584 | Lymphoma | bleomycin sulfa... ABVD regimen BEACOPP regimen epirubicin hydr... prednisone vinblastine sul... radiation thera... | 15 Years - 70 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Combination Chemotherapy in Treating Patients With Stage II Bladder Cancer | NCT00002919 | Bladder Cancer | filgrastim cisplatin doxorubicin hyd... methotrexate vinblastine sul... conventional su... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer | NCT00030654 | Prostate Cancer | bicalutamide docetaxel doxorubicin hyd... estramustine ph... flutamide ketoconazole paclitaxel releasing hormo... vinblastine sul... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma | NCT00030459 | Malignant Mesot... | cisplatin mitomycin C vinblastine sul... vinorelbine tar... | - | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease | NCT00004010 | Lymphoma | bleomycin sulfa... filgrastim ABVD regimen cyclophosphamid... dacarbazine doxorubicin hyd... etoposide prednisone procarbazine hy... vinblastine sul... vincristine sul... radiation thera... | - 21 Years | Children's Oncology Group | |
| PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma | NCT03226249 | Classical Hodgk... Lymphocyte-Depl... Lymphocyte-Rich... Mixed Cellulari... Nodular Scleros... | Computed Tomogr... Dacarbazine Doxorubicin Hyd... Fludeoxyglucose... Laboratory Biom... Pembrolizumab Positron Emissi... Vinblastine Sul... | 18 Years - | Northwestern University | |
| Combination Chemotherapy in Treating Young Male Patients With Hodgkin's Lymphoma | NCT00398554 | Lymphoma | cyclophosphamid... doxorubicin hyd... etoposide prednisone vinblastine sul... vincristine sul... radiation thera... | - 18 Years | Martin-Luther-Universität Halle-Wittenberg |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
